News
CV
5.86
+3.35%
0.19
CapsoVision 10% owner Eliyahou Harari reports purchase of 13,850 common shares worth $101,782.35
PUBT · 12h ago
Weekly Report: what happened at CV last week (0629-0703)?
Weekly Report · 2d ago
CapsoVision adds Shields to board, refines clinical focus
TipRanks · 5d ago
CapsoVision director David Stanley Shields files initial beneficial ownership statement
PUBT · 5d ago
CapsoVision names gastroenterologist David S. Shields to board of directors
PUBT · 5d ago
*CapsoVision: Shields Succeeds Joanne C. Imperial >CV
Dow Jones · 5d ago
CAPSOVISION APPOINTS GASTROENTEROLOGY LEADER DAVID S. SHIELDS, M.D., TO BOARD OF DIRECTORS
Reuters · 5d ago
Press Release: CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
Dow Jones · 5d ago
*CapsoVision Names David S. Shields to Board
Dow Jones · 5d ago
Benchmark refreshes 'best ideas' roster
Seeking Alpha · 07/01 13:35
Weekly Report: what happened at CV last week (0622-0626)?
Weekly Report · 06/29 09:44
Weekly Report: what happened at CV last week (0615-0619)?
Weekly Report · 06/22 09:49
Weekly Report: what happened at CV last week (0608-0612)?
Weekly Report · 06/15 09:50
CapsoVision Stockholders Reelect Directors, Ratify 2026 Auditor
TipRanks · 06/12 18:27
CapsoVision shareholders re-elect Class I directors at annual meeting
PUBT · 06/12 18:14
Weekly Report: what happened at CV last week (0601-0605)?
Weekly Report · 06/08 09:47
Weekly Report: what happened at CV last week (0525-0529)?
Weekly Report · 06/01 09:50
Weekly Report: what happened at CV last week (0518-0522)?
Weekly Report · 05/25 09:52
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 05/18 21:05
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Benzinga · 05/18 12:02
More
Webull provides a variety of real-time CV stock news. You can receive the latest news about CapsoVision, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About CV
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.